Literature DB >> 24190732

Determination of 7-ketocholesterol in plasma by LC-MS for rapid diagnosis of acid SMase-deficient Niemann-Pick disease.

Na Lin1, Huiwen Zhang, Wenjuan Qiu, Jun Ye, Lianshu Han, Yu Wang, Xuefan Gu.   

Abstract

Acid sphingomyelinase (ASMase)-deficient Niemann-Pick disease (NPD) is caused by mutations in the sphingomyelin phosphodiesterase 1 (SMPD1) gene, resulting in accumulation of sphingomyelin in the lysosomes and secondary changes in cholesterol metabolism. We hypothesized that the oxidation product of cholesterol, 7-ketocholesterol (7-KC), might increase in the plasma of patients with ASMase-deficient NPD. In this study, a rapid and nonderivatized method of measurement of plasma 7-KC by liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed. Plasma samples from healthy subjects, patients with ASMase-deficient NPD, nonaffected ASMase-deficient NPD heterozygotes, Niemann-Pick type C (NPC) disease, glycogen storage disorder type II (GSDII), Gaucher disease (GD), mucopolysaccharidosis type II (MPSII), Krabbe disease (KD), and metachromatic leukodystrophy (MLD) were tested retrospectively. Markedly elevated 7-KC was found in patients with ASMase-deficient NPD and NPC disease that showed significant differences from ASMase-deficient NPD heterozygotes; patients with GSDII, GD, MPSII, KD, and MLD; and normal controls. The analysis of plasma 7-KC by LC-MS/MS offers the first simple, quantitative, and highly sensitive method for detection of ASMase-deficient NPD and could be useful in the diagnosis of both ASMase-deficient NPD and NPC disease.

Entities:  

Keywords:  genetics; mass spectrometry; oxysterols; storage diseases

Mesh:

Substances:

Year:  2013        PMID: 24190732      PMCID: PMC3886673          DOI: 10.1194/jlr.D044024

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  28 in total

1.  Derivatization reagents in liquid chromatography/electrospray ionization tandem mass spectrometry for biomedical analysis.

Authors:  T Santa; O Y Al-Dirbashi; T Fukushima
Journal:  Drug Discov Ther       Date:  2007-10

2.  Natural history of Type A Niemann-Pick disease: possible endpoints for therapeutic trials.

Authors:  M M McGovern; A Aron; S E Brodie; R J Desnick; M P Wasserstein
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

Review 3.  Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges.

Authors:  R J Desnick; E H Schuchman
Journal:  Annu Rev Genomics Hum Genet       Date:  2012       Impact factor: 8.929

4.  Identification and characterization of eight novel SMPD1 mutations causing types A and B Niemann-Pick disease.

Authors:  Jonathan P Desnick; Jungmin Kim; Xingxuan He; Melissa P Wasserstein; Calogera M Simonaro; Edward H Schuchman
Journal:  Mol Med       Date:  2010-04-06       Impact factor: 6.354

5.  Highly sensitive quantification of 7alpha-hydroxy-4-cholesten-3-one in human serum by LC-ESI-MS/MS.

Authors:  Akira Honda; Kouwa Yamashita; Mitsuteru Numazawa; Tadashi Ikegami; Mikio Doy; Yasushi Matsuzaki; Hiroshi Miyazaki
Journal:  J Lipid Res       Date:  2006-11-08       Impact factor: 5.922

6.  A prospective, cross-sectional survey study of the natural history of Niemann-Pick disease type B.

Authors:  Margaret M McGovern; Melissa P Wasserstein; Roberto Giugliani; Bruno Bembi; Marie T Vanier; Eugen Mengel; Scott E Brodie; David Mendelson; Gwen Skloot; Robert J Desnick; Noriko Kuriyama; Gerald F Cox
Journal:  Pediatrics       Date:  2008-07-14       Impact factor: 7.124

7.  Lipid abnormalities in children with types A and B Niemann Pick disease.

Authors:  Margaret M McGovern; Tilla Pohl-Worgall; Richard J Deckelbaum; William Simpson; David Mendelson; Robert J Desnick; Edward H Schuchman; Melissa P Wasserstein
Journal:  J Pediatr       Date:  2004-07       Impact factor: 4.406

Review 8.  The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease.

Authors:  E H Schuchman
Journal:  J Inherit Metab Dis       Date:  2007-07-12       Impact factor: 4.982

9.  Correction of enzyme levels with allogeneic hematopoeitic progenitor cell transplantation in Niemann-Pick type B.

Authors:  Jennifer Schneiderman; Kimberly Thormann; Joel Charrow; Morris Kletzel
Journal:  Pediatr Blood Cancer       Date:  2007-12       Impact factor: 3.167

10.  Morbidity and mortality in type B Niemann-Pick disease.

Authors:  Margaret M McGovern; Natalie Lippa; Emilia Bagiella; Edward H Schuchman; Robert J Desnick; Melissa P Wasserstein
Journal:  Genet Med       Date:  2013-02-14       Impact factor: 8.822

View more
  21 in total

Review 1.  The Extending Spectrum of NPC1-Related Human Disorders: From Niemann-Pick C1 Disease to Obesity.

Authors:  Amel Lamri; Marie Pigeyre; William S Garver; David Meyre
Journal:  Endocr Rev       Date:  2018-04-01       Impact factor: 19.871

Review 2.  Lysosomal diseases: diagnostic update.

Authors:  Bryan Winchester
Journal:  J Inherit Metab Dis       Date:  2014-04-08       Impact factor: 4.982

3.  Detection and confirmation of serum lipid biomarkers for preeclampsia using direct infusion mass spectrometry.

Authors:  Swati Anand; SydneyA Young; M Sean Esplin; Benjamin Peaden; H Dennis Tolley; T Flint Porter; Michael W Varner; Mary E D'Alton; Bruce J Jackson; Steven W Graves
Journal:  J Lipid Res       Date:  2016-02-18       Impact factor: 5.922

Review 4.  Complex lipid trafficking in Niemann-Pick disease type C.

Authors:  Marie T Vanier
Journal:  J Inherit Metab Dis       Date:  2014-11-26       Impact factor: 4.982

5.  Niemann-Pick Type C-2 Disease: Identification by Analysis of Plasma Cholestane-3β,5α,6β-Triol and Further Insight into the Clinical Phenotype.

Authors:  J Reunert; A S Lotz-Havla; G Polo; F Kannenberg; M Fobker; M Griese; E Mengel; A C Muntau; P Schnabel; O Sommerburg; I Borggraefe; A Dardis; A P Burlina; M A Mall; G Ciana; B Bembi; A B Burlina; T Marquardt
Journal:  JIMD Rep       Date:  2015-03-13

6.  Advancing Diagnosis and Treatment of Niemann-Pick C disease through Biomarker Discovery.

Authors:  Xuntian Jiang; Daniel S Ory
Journal:  Explor Neuroprotective Ther       Date:  2021-12-30

7.  New variants in Spanish Niemann-Pick type c disease patients.

Authors:  Laura López de Frutos; Jorge J Cebolla; Luis Aldámiz-Echevarría; Ángela de la Vega; Sinziana Stanescu; Carlos Lahoz; Pilar Irún; Pilar Giraldo
Journal:  Mol Biol Rep       Date:  2020-02-14       Impact factor: 2.316

Review 8.  Diagnostic workup and management of patients with suspected Niemann-Pick type C disease.

Authors:  Apostolos Papandreou; Paul Gissen
Journal:  Ther Adv Neurol Disord       Date:  2016-03-02       Impact factor: 6.570

9.  Evaluation of plasma cholestane-3β,5α,6β-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism.

Authors:  Sara Boenzi; Federica Deodato; Roberta Taurisano; Bianca Maria Goffredo; Cristiano Rizzo; Carlo Dionisi-Vici
Journal:  J Lipid Res       Date:  2016-01-05       Impact factor: 5.922

10.  Cholestane-3β,5α,6β-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency.

Authors:  Sonia Pajares; Angela Arias; Judit García-Villoria; Judit Macías-Vidal; Emilio Ros; Javier de las Heras; Marisa Girós; Maria J Coll; Antonia Ribes
Journal:  J Lipid Res       Date:  2015-08-03       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.